Juliette Berangere Audet

Insider Reports History

Entity
Individual
Location
C/O Newamsterdam Pharma Company N.V., Gooimeer 2 35, Naarden, Netherlands
Signature
/s/ Juliette Berangere Audet
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Juliette Berangere Audet:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NewAmsterdam Pharma Co N.V. Chief Business Officer Ordinary Shares 15.1K $386K $25.54 Jan 7, 2025 Direct
NewAmsterdam Pharma Co N.V. Chief Business Officer Option (right to buy) 250K Apr 1, 2024 Direct
NewAmsterdam Pharma Co N.V. Chief Business Officer Option (right to buy) 100K Jan 2, 2025 Direct

Insider Reports Filed by Juliette Berangere Audet

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NAMS NewAmsterdam Pharma Co N.V. Jan 7, 2025 1 $0 4 Jan 7, 2025 Chief Business Officer
NAMS NewAmsterdam Pharma Co N.V. Jan 2, 2025 1 $0 4 Jan 6, 2025 Chief Business Officer
NAMS NewAmsterdam Pharma Co N.V. Sep 26, 2024 1 $17.3K 4 Sep 30, 2024 Chief Business Officer
NAMS NewAmsterdam Pharma Co N.V. Apr 1, 2024 1 $0 4 Apr 2, 2024 Chief Business Officer
NAMS NewAmsterdam Pharma Co N.V. Dec 29, 2023 0 $0 3 Dec 29, 2023 Director